New drug study tests liver impact on medication processing

NCT ID NCT07165002

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how a drug called LY3537031 moves through the body in people with mild, moderate, or severe liver problems compared to healthy volunteers. About 32 adults will receive a single injection under the skin. The goal is to understand how liver function affects drug levels and safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hepatic Insufficiency liver disorder liver failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinical Research Units Hungary

    RECRUITING

    Kistarcsa, H-243, Hungary

  • New Zealand Clinical Research Auckland

    RECRUITING

    Auckland, 1010, New Zealand

  • Summit Clinical Research, s.r.o. - Bratislava

    RECRUITING

    Bratislava, 831 01, Slovakia

More trials for these conditions

Other studies related to the condition(s) this trial covers.